Dopaminergic nervous transmission in Parkinson's disease.
D000110:Acetylcholinesterase / Q000378:metabolism; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001344:Autopsy; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D001923:Brain Chemistry / Q000187:drug effects; D004247:DNA / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D004296:Dopa Decarboxylase / Q000494:pharmacology / Q000627:therapeutic use; D004298:Dopamine / Q000378:metabolism*; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D010300:Parkinson Disease / Q000134:cerebrospinal fluid* / Q000188:drug therapy / Q000378:metabolism; D011339:Probenecid / Q000494:pharmacology; D012313:RNA / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism; D013268:Stimulation, Chemical; D009435:Synaptic Transmission / Q000187:drug effects; D013997:Time Factors
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D004295:Dihydroxyphenylalanine; D012313:RNA; D004247:DNA; D000110:Acetylcholinesterase; D004296:Dopa Decarboxylase; D011339:Probenecid; D004298:Dopamine; D009638:Norepinephrine; D006719:Homovanillic Acid